ClinicalTrials.gg
Sign In
CompletedNCT01339728Updated Apr 21, 2011

Far-infrared Ray Effect on CV12 Acupoint

An interventional study of far-infrared ray in Reaction of Far Infrared Ray and Reaction of Skin Temperature, sponsored by China Medical University Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-04-21.

Sponsored by China Medical University Hospital · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

The purpose of the present study was to investigate the effect of far-infrared ray at CV12 acupoints area on the skin temperature and skin blood flow of palm central area of right hand, and the correlation between them.

Read the detailed description

The purpose of the present study was to investigate the effect of far-infrared ray at CV12 acupoints area (the center is CV12 acupoints and the diameter is 10 cm) on the skin temperature and skin blood flow of palm central area of right hand, and the correlation between them.

02

Conditions studied

  • Reaction of Far Infrared Ray
  • Reaction of Skin Temperature
03

In context

Lead sponsor

China Medical University Hospital is the lead sponsor of 479 studies on the registry; 115 are open to participants now.

Browse China Medical University Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adult volunteers, male or female, ages between 20 and 40 years
  • Neurological and physical examination without abnormal functions
  • Far-infrared ray illumination without allergic reaction and contra- indication
  • The participants were explained the objective of the study, agreed to accept the test and signed a letter of consent

Exclusion criteria

Exclusion Criteria:

  • People less than 20 years of age or more than 40 years
  • Women in pregnant or lactating
  • People with mental or behavioral anomalies could not follow the researchers
  • People suffered from serious diseases such as myocardial infarction , heart failure, serious arrhythmia, hypertension, diabetes, autoimmune disease, chronic obstructive pulmonary diseases, and kidney failure, liver cirrhosis and cancer
  • People suffered from limb edema and serious skin diseases
  • People did not sign a letter of consent
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
22 participants (actual)

Interventions

  • Procedurefar-infrared ray

    The duration of far-infrared ray is 20 minutes.

06

What researchers measure

Primary outcomes

  1. far-infrared ray on CV12 acupoint area may increase the skin temperature

    Time frame: Each period was 20 min in duration

07

Study locations

1 site
  • China Medical University Hospital
    Taichung, 404, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01339728
Lead sponsor
China Medical University Hospital
First posted
Apr 21, 2011
Start date
Oct 2010
Primary completion
Apr 2011
Completion
Apr 2011
Last update
Apr 21, 2011

Study contacts

Ching-Liang Hsieh, professor
study chair · China Medical University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

China Medical University Hospital →

Start the discussion